We develop, manufacture, and market aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to performnon-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women’s health. We also market radiofrequency, or RF, energy-sourced medical devices for precision surgical applications such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. Our product portfolio is composed of a broad range of energy sources including Alexandrite, diode, Nd: YAG, picosecond, pulse dye,Q-switched lasers, intense pulsed light and RF technology. We sell our products globally under the Cynosure, Palomar, ConBio and Ellman brand names through a direct sales force in the United States, Canada, France, Morocco, Germany, Spain, the United Kingdom, Australia, China, Japan and Korea, and through international distributors in over 120 other countries.
Company profile
Ticker
CYNO
Exchange
Employees
Location
Fiscal year end
Industry (SIC)
Medtronic • Varian Medical Systems • Conmed • Integer • Masimo • Natus Medical • LivaNova • BioPlus Acquisition • QT Imaging • Outset Medical ...
SEC CIK
Corporate docs
IRS number
43125110
Latest filings (excl ownership)
15-12G
Securities registration termination
6 Apr 17
EFFECT
Notice of effectiveness
29 Mar 17
8-K
Completion of Acquisition or Disposition of Assets
23 Mar 17
25-NSE
Exchange delisting
22 Mar 17
POS AM
Prospectus update (post-effective amendment)
22 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Mar 17
S-8 POS
Registration of securities for employees (post-effective amendment)
22 Mar 17
Latest ownership filings
SC 13G/A
Cynosure Inc
9 Feb 18
4
Stephen J. Webber
24 Mar 17
4
Douglas J Delaney
24 Mar 17
4
Thomas H Robinson
24 Mar 17
4
Marina Hatsopoulos
24 Mar 17
4
Ettore V Biagioni
24 Mar 17
4
BRIAN M. BAREFOOT
24 Mar 17
4
Michael R Davin
24 Mar 17
4
William O. Flannery
24 Mar 17
SC 13G
Cynosure Inc
24 Feb 17
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|